| Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor Y Zheng, M Peng, Z Wang, JM Asara, AL Tyner Molecular and cellular biology 30 (17), 4280-4292, 2010 | 82 | 2010 |
| Cloning and Characterization of a Rice Field Eel vasa-Like Gene cDNA and Its Expression in Gonads During Natural Sex Transformation D Ye, D Lv, P Song, M Peng, Y Chen, M Guo, Q Yang, Y Hu Biochemical genetics 45, 211-224, 2007 | 46 | 2007 |
| PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors M Peng, R Emmadi, Z Wang, EL Wiley, PH Gann, SA Khan, N Banerji, ... Oncotarget 5 (15), 6038, 2014 | 40 | 2014 |
| Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse M Peng, SM Ball-Kell, AL Tyner Cell death & disease 6 (8), e1848-e1848, 2015 | 22 | 2015 |
| Current strategies employed in the manipulation of gene expression for clinical purposes HC Tsai, V Pietrobon, M Peng, S Wang, L Zhao, FM Marincola, Q Cai Journal of Translational Medicine 20 (1), 535, 2022 | 17 | 2022 |
| Protein tyrosine kinase 6 regulates mammary gland tumorigenesis in mouse models M Peng, SM Ball-Kell, RR Franks, H Xie, AL Tyner Oncogenesis 2 (12), e81-e81, 2013 | 17 | 2013 |
| Molecular cloning and sequence analysis of full-length growth hormone cDNAs from six important economic fishes JN Zhang, P Song, JR Hu, SJ Mo, MY Peng, W Zhou, JX Zou, YC Hu ActaGeneticaSinica 32 (1), 19-29, 2005 | 10 | 2005 |
| Polymorphism in intron 2 of crucian carp GH I gene SJ Mo, P Song, DJ Luo, MY Peng, L Zhang, HL Yao, W Zhou, JN Zhang, ... Yi Chuan Xue Bao= Acta Genetica Sinica 31 (6), 582-590, 2004 | 7 | 2004 |
| Inhibition of PI3K Alpha and PI3K delta with copanlisib shows preclinical activity as a single agent and in combination in multiple myeloma SM Larson, MY Peng, M Mead, A Vandross, D Conklin, E Von Euw, ... Blood 130, 3084, 2017 | 3 | 2017 |
| Fatty acid synthase (FASN) inhibitors synergize with carfilzomib (CFZ) in acute myeloid leukemia (AML) and multiple myeloma (MM) M Peng, SN Ghafouri, MSJ McDermott, DJ Slamon, SM Larson Cancer Research 82 (12_Supplement), 3023-3023, 2022 | 1 | 2022 |
| Activity of carfilzomib (CFZ) in acute myeloid leukemia (AML) as a single agent and in novel combinations MY Peng, Y Abaza, M Mcdermott, M Mead, DJ Slamon, S Larson Blood 136, 6-7, 2020 | 1 | 2020 |
| Phospho-S6 levels correlate with response to Copanlisib (BAY 80-6946) in multiple myeloma S Larson, MY Peng, M Mead, A Vandross, D Conklin, EV Euw, DJ Slamon Cancer Research 77 (13_Supplement), 136-136, 2017 | 1 | 2017 |
| Activity of carfilzomib (CFZ) alone and in combination with cytarabine and chloroquine diphosphate (CHQ) in acute myeloid leukemia (AML) MY Peng, Y Abaza, D Conklin, EV Euw, M Mead, J Timmerman, ... Cancer Research 79 (13_Supplement), 297-297, 2019 | | 2019 |
| Copanlisib Has Activity As a Single Agent and in Combination with Carfilzomib and Response Correlates with Phospho-S6 Level S Larson, MY Peng, A Vandross, M Mead, E Von Euw, D Conklin, ... Clinical Lymphoma, Myeloma and Leukemia 17 (1), e132, 2017 | | 2017 |
| Activity of the Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Copanlisib, As a Single Agent and in Combination with Carfilzomib in Multiple Myeloma SM Larson, MY Peng, A Vandross, M Mead, Z Fuchs, D Conklin, ... Blood, The Journal of the American Society of Hematology 128 (22), 5665-5665, 2016 | | 2016 |
